Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(50%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
1
50%
Ph early_phase_1
1
50%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Completed(1)

Detailed Status

Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (50.0%)
Phase 21 (50.0%)

Trials by Status

completed150%
recruiting150%

Recent Activity

1 active trials
Showing 2 of 2
recruitingearly_phase_1

Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis

NCT07569419
completedphase_2

MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

NCT00090064

Clinical Trials (2)

Showing 2 of 2 trials
NCT07569419Early Phase 1

Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis

Recruiting
NCT00090064Phase 2

MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

Completed

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2